Hemoglobin changes during long-lasting frontline treatment with Tyrosine-Kinase inhibitors in patients with chronic myeloid leukemia

Latagliata R et al. Leuk Lymphoma, November 2025 (epub ahead of print)

• Share
• Tweet
• Share
• Share